ライフサイエンスコーパス: cardiometabolic risk factor

1 Fat distribution is an independent cardiometabolic risk factor.

2 ceral adiposity, is emerging as a recognized cardiometabolic risk factor.

3 y), and 70% of the children had at least one cardiometabolic risk factor.

4 defined by hepatic steatosis plus at least 1 cardiometabolic risk factor.

5 up land use within 300 m of the home and all cardiometabolic risk factors.

6 onsistently associated with higher levels of cardiometabolic risk factors.

7 tem with food-group and nutrient intakes and cardiometabolic risk factors.

8 for demographic, diet, lifestyle, and other cardiometabolic risk factors.

9 levels of SDMA, AGXT2 variants, and various cardiometabolic risk factors.

10 urements included changes in body weight and cardiometabolic risk factors.

11 olescent females, AMH is not associated with cardiometabolic risk factors.

12 ETC-1002 may have favorable effects on other cardiometabolic risk factors.

13 oth groups underwent intensive management of cardiometabolic risk factors.

14 s in treating hypercholesterolemia and other cardiometabolic risk factors.

15 rtant reductions in body weight and improved cardiometabolic risk factors.

16 r the identification of adults with elevated cardiometabolic risk factors.

17 y in the absence of the associated burden of cardiometabolic risk factors.

18 imate the effect of environmental factors on cardiometabolic risk factors.

19 significant weight loss and improvements in cardiometabolic risk factors.

20 expenditure (REE), satiety and appetite, and cardiometabolic risk factors.

21 vascular risk, independently of conventional cardiometabolic risk factors.

22 white rice by substituting beans, may lower cardiometabolic risk factors.

23 25(OH)D and prevalence of MetSyn and several cardiometabolic risk factors.

24 he associations between urban life-years and cardiometabolic risk factors.

25 ce, and sugar-sweetened beverages (SSBs) and cardiometabolic risk factors.

26 a key independent role in the modulation of cardiometabolic risk factors.

27 ificant weight loss and favorable changes in cardiometabolic risk factors.

28 explained, at most, 8% of the variability in cardiometabolic risk factors.

29 eatment Panel III definition) and individual cardiometabolic risk factors.

30 strongest correlations between VAT area and cardiometabolic risk factors.

31 d their weight loss and favorable changes in cardiometabolic risk factors.

32 waist circumference and favorable changes in cardiometabolic risk factors.

33 ircumference, plasma lipid levels, and other cardiometabolic risk factors.

34 play an important role in the genesis of key cardiometabolic risk factors.

35 ), adjusting for demographic, lifestyle, and cardiometabolic risk factors.

36 ime ambulatory blood pressure (BP) and other cardiometabolic risk factors.

37 e frequent for patients with CVD but not for cardiometabolic risk factors.

38 nds who have cardiovascular disease (CVD) or cardiometabolic risk factors.

39 s previously observed between UPF intake and cardiometabolic risk factors.

40 points (MEGASTROKE, Cardiogram, DIAGRAM) and cardiometabolic risk factors.

41 der adults in Iran with distinct patterns of cardiometabolic risk factors.

42 % CI: 1.10-2.42), even after controlling for cardiometabolic risk factors.

43 o significant changes were observed in other cardiometabolic risk factors.

44 tabolic alterations occurring in response to cardiometabolic risk factors.

45 n, women with PCOS have a high prevalence of cardiometabolic risk factors.

46 present a blood DNA methylation signature of cardiometabolic risk factors.

47 abetes diagnosis and interactions with other cardiometabolic risk factors.

48 ificant burden of cardiovascular disease and cardiometabolic risk factors.

49 in meters squared) and 1 or more additional cardiometabolic risk factors.

50 ox regression models, adjusting for relevant cardiometabolic risk factors.

51 ectively treat obesity and manage associated cardiometabolic risk factors.

52 on the impact of avocado-containing diets on cardiometabolic risk factors.

53 Fatty Liver Index >= 60 and the presence of cardiometabolic risk factors.

54 ronic liver disease strongly associated with cardiometabolic risk factors.

55 ietary factors, anthropometric measures, and cardiometabolic risk factors.

56 h habitual short sleep duration and existing cardiometabolic risk factors.

57 disease-specific covariates including common cardiometabolic risk factors.

58 to enhance the monitoring and management of cardiometabolic risk factors.

59 nuous energy restriction for weight loss and cardiometabolic risk factors.

60 s in the population distribution of multiple cardiometabolic risk factors.

61 oung adulthood was explored by investigating cardiometabolic risk factors.

62 th equivalent energy from 1 avocado daily on cardiometabolic risk factors.

63 impairment and is not confounded by various cardiometabolic risk factors.

64 asured by whole-body MRI after adjusting for cardiometabolic risk factors.

65 mine the effect of low AGE diets in reducing cardiometabolic risk factors.

66 ignificant effects on several other nonlipid cardiometabolic risk factors.

67 p bridge the equity gap in the management of cardiometabolic risk factors.

68 ffects of n-3 (omega-3) fatty acids (FAs) on cardiometabolic risk factors.

69 rts higher-protein diets for improvements in cardiometabolic risk factors.

70 Olive oil has been shown to improve various cardiometabolic risk factors.

71 All analyses were adjusted for cardiometabolic risk factors.

72 , adjusting for demographic, behavioral, and cardiometabolic risk factors.

73 .9 mg/dL}]) (17 studies), and improved other cardiometabolic risk factors.

74 musculoskeletal fitness (0.59 [0.31-0.87]), cardiometabolic risk factors (0.39 [0.04-0.75]), and bra

75 gh 2012 to assess the prevalence of multiple cardiometabolic risk factors according to the severity o

76 ficacy of tirzepatide in improving different cardiometabolic risk factors across individuals and subp

77 r levels of MVPA were associated with better cardiometabolic risk factors across tertiles of sedentar

78 advantage, perceived neighborhood safety and cardiometabolic risk factors, adjusting for health behav

79 birthweight associated variants on offspring cardiometabolic risk factors after adjusting for offspri

80 irthweight is also associated with offspring cardiometabolic risk factors, after controlling for offs

81 Measurements were also made of the cardiometabolic risk factors age, systolic blood pressur

82 h AF, elevated BMI, and 1 or more additional cardiometabolic risk factors, aggressive risk factor man

83 olic fatty liver disease are associated with cardiometabolic risk factors already in childhood.

84 Early life undernutrition is a novel cardiometabolic risk factor among immigrants associated

85 Furthermore, cardiometabolic risk factors among pregnant individuals

86 Retrospectively, we analysed trajectories of cardiometabolic risk factors and 10 year cardiovascular

87 ts colocalize between C-reactive protein and cardiometabolic risk factors and 12 of them display unex

88 In patients with FES, cardiometabolic risk factors and abnormalities are prese

89 Associations among cardiometabolic risk factors and BMI and WC were evaluat

90 to infer causal relationships between eight cardiometabolic risk factors and coronary artery disease

91 Cardiometabolic risk factors and CVD events were assesse

92 hazards models evaluated sex differences in cardiometabolic risk factors and CVD risk over follow-up

93 Secondary outcomes included 6-mo changes in cardiometabolic risk factors and diet.

94 studies have demonstrated associations with cardiometabolic risk factors and diseases, its genetic b

95 Both chronic cardiometabolic risk factors and genetics have been show

96 This study examined prepregnancy cardiometabolic risk factors and gestational diabetes me

97 diet was associated with improvement in some cardiometabolic risk factors and greater reduction in ad

98 MASLD and liver fibrosis are associated with cardiometabolic risk factors and health-related quality

99 tem that reduces NCD risk factors, including cardiometabolic risk factors and infections that are pre

100 re few therapeutic recommendations for these cardiometabolic risk factors and little evidence of thei

101 ignatures were significantly associated with cardiometabolic risk factors and metabolically unhealthy

102 However, we observed different changes in cardiometabolic risk factors and nutritional markers bet

103 long-term health outcomes, including several cardiometabolic risk factors and outcomes.

104 We examined cardiometabolic risk factors and pathways associated wit

105 The authors measured prepregnancy cardiometabolic risk factors and performed multivariate

106 we investigated whether associations between cardiometabolic risk factors and prevalent cognitive imp

107 hort (subcohort) received a questionnaire on cardiometabolic risk factors and QoL.

108 suggest that late eating is associated with cardiometabolic risk factors and reduced efficacy of a w

109 e outcomes, and to assess optimal levels for cardiometabolic risk factors and risk associated with mu

110 abolites have differential associations with cardiometabolic risk factors and subtypes of vascular di

111 a novel determinant of diagnostic value for cardiometabolic risk factors and suggest Rap1 as a promi

112 amine potential causal relationships between cardiometabolic risk factors and upper UTIs.

113 Ageing is accelerated by cardiometabolic risk factors and we also identify prescr

114 Studies showed improvements in cardiometabolic risk factors and, in several, androgen e

115 a history of diabetes, stroke as well as 1-2 cardiometabolic risk factors and/or chronic conditions w

116 s, pathological short stature, macrocephaly, cardiometabolic risk factors, and adult noncommunicable

117 models adjusted for demographics, insurance, cardiometabolic risk factors, and baseline hemoglobin A1

118 d with superior weight loss, improvements in cardiometabolic risk factors, and fatty liver disease ma

119 iferation/ex-vivo cytokine secretion, plasma cardiometabolic risk factors, and fecal bile acid concen

120 nt, muscle and abdominal fat, liver enzymes, cardiometabolic risk factors, and gut microbiome were as

121 r age, sex, potential confounders related to cardiometabolic risk factors, and lifestyle and dietary

122 r age, sex, potential confounders related to cardiometabolic risk factors, and lifestyle.

123 cal coupling appreciated with advancing age, cardiometabolic risk factors, and structural heart disea

124 d to determine associations between Lp-PLA2, cardiometabolic risk factors, and subclinical atheroscle

125 anges in body weight, coexisting conditions, cardiometabolic risk factors, and weight-related quality

126 LDL-C (primary endpoint), other lipids, and cardiometabolic risk factors; and safety.

127 associations between infant growth and adult cardiometabolic risk factors (anthropometric characteris

128 on of vitamin D supplementation in reversing cardiometabolic risk factors appears to be warranted.

129 verse associations between abdominal SAT and cardiometabolic risk factors are attenuated and, in the

130 r's metabolic product, oleic acid (18:1), on cardiometabolic risk factors are limited.

131 d-effects models to estimate mean changes in cardiometabolic risk factors associated with changes in

132 insulin resistance, dyslipidemia, and other cardiometabolic risk factors associated with NAFLD.

133 t consistently associated with organ fat and cardiometabolic risk factors at 10 y.

134 Secondary outcomes included weight loss and cardiometabolic risk factors at 12 and 24 months.

135 of change in body mass index (BMI) and other cardiometabolic risk factors before type 2 diabetes diag

136 SSB intakes are associated with increases in cardiometabolic risk factors between 14 and 17 y of age.

137 aist circumference, fat, and lean mass), and cardiometabolic risk factors (blood pressure and fasting

138 during childhood (up to 18 years of age) and cardiometabolic risk factors (body mass index, fat mass

139 h temporal changes in 3 objectively measured cardiometabolic risk factors: body mass index, systolic

140 s in infancy and induces inflammation, a key cardiometabolic risk factor, but the relationship betwee

141 d with level of alanine aminotransferase and cardiometabolic risk factors, but not body mass index.

142 ty, several chronic diseases, and a range of cardiometabolic risk factors, but there is no convincing

143 motes cardiorespiratory fitness and improves cardiometabolic risk factors, but with great heterogenei

144 ildhood adiposity is associated with adverse cardiometabolic risk factors, but with no evidence of va

145 The changes in cardiometabolic risk factors by degree of tirzepatide-in

146 Changes from baseline to week 72 in cardiometabolic risk factors by weight reduction.

147 is disproportionately higher in people with cardiometabolic risk factors, cardiovascular diseases, c

148 egated pre- and post-intervention weight and cardiometabolic risk factor changes (fasting blood gluco

149 No prior analyses have aggregated weight and cardiometabolic risk factor changes observed in studies

150 Associations between cardiometabolic risk factors, chronic disease, and retin

151 ed in 2022 to investigate associations among cardiometabolic risk factors, circulating biomarkers, an

152 d fibrosis was associated with the number of cardiometabolic risk factors (CMRF) in lean (OR=2.06, P=

153 e the association between uric acid (UA) and cardiometabolic risk factors (CMRFs) by sex in youth wit

154 loss and sustained improvements in HbA1c and cardiometabolic risk factors compared with medical manag

155 ietary sugar with other carbohydrates affect cardiometabolic risk factors, comparing different interv

156 Efforts to prevent YOD and intensify cardiometabolic risk factor control while focusing on me

157 intervention strategy are needed to improve cardiometabolic risk factor control.

158 Although diet response prediction for cardiometabolic risk factors (CRFs) has been demonstrate

159 ntive interventions for diabetes can improve cardiometabolic risk factors (CRFs), but it is unclear w

160 mic metabolic dysregulation when traditional cardiometabolic risk factors cross current diagnostic th

161 Among overweight women, 26.7% with 1 or more cardiometabolic risk factors developed GDM versus 7.4% w

162 mediated by related comorbidities, including cardiometabolic risk factors (diabetes mellitus, hyperte

163 lely to increased body weight and associated cardiometabolic risk factors (e.g.,dyslipidemia or hyper

164 t, offspring GRS is strongly related to many cardiometabolic risk factors, even after conditioning on

165 moves to an urban environment, whereas other cardiometabolic risk factors evolve gradually.

166 Associations between fast build-up and all cardiometabolic risk factors except non-HDL cholesterol

167 tantial reduction in routine measurements of cardiometabolic risk factors following the COVID-19 pand

168 All other cardiometabolic risk factors, food intake, physical acti

169 Dietitians play a critical role in improving cardiometabolic risk factors for adults with elevated BP

170 sepsis was mediated through a combination of cardiometabolic risk factors for sepsis (body mass index

171 Sociodemographic, behavioural, and cardiometabolic risk factors from 1985 and chronic condi

172 Offspring born to mothers with any cardiometabolic risk factors had higher SBP (4.88 percen

173 other races and ethnicities or data based on cardiometabolic risk factors had no significant change.

174 ans, yet the combined role of these foods on cardiometabolic risk factors has not been studied.

175 come of MI and ischemic stroke, adjusted for cardiometabolic risk factors (hazard ratio [HR] for quar

176 to examine relations of plasma measures with cardiometabolic risk factors, history of cardiovascular

177 a choline and choline-related compounds with cardiometabolic risk factors, history of cardiovascular

178 Regular exercise improves many cardiometabolic risks factors; however, its effect on in

179 assessed the burden and correlates of three cardiometabolic risk factors, (hypertension, diabetes, a

180 rnoon is somewhat more efficient at reducing cardiometabolic risk factors (i.e. systolic blood pressu

181 entional studies reporting the prevalence of cardiometabolic risk factors (ie, diabetes, hypertension

182 as not explained by disturbances in the main cardiometabolic risk factors, ie, high body mass index,

183 ted weeks of gestation), including increased cardiometabolic risk factors, impaired glucose metabolis

184 the relations between obesity indicators and cardiometabolic risk factors in 324 Chilean children 4 y

185 med to assess whether AMH is associated with cardiometabolic risk factors in a general population of

186 ssociated with abdominal adiposity and other cardiometabolic risk factors in a sample of women 4-12 y

187 trajectories of insulin resistance and other cardiometabolic risk factors in a white, British populat

188 ese maternal attributes are related to other cardiometabolic risk factors in adulthood has not been c

189 nted younger and had increased prevalence of cardiometabolic risk factors in all GRACE risk groups.

190 esidential surrounding built-up land use and cardiometabolic risk factors in an urbanizing peri-urban

191 SAT area on subclinical atherosclerosis and cardiometabolic risk factors in both whites and African

192 among healthy term infants did not influence cardiometabolic risk factors in childhood.

193 eased duration of exclusive breastfeeding on cardiometabolic risk factors in childhood.

194 and distribution but are not associated with cardiometabolic risk factors in childhood.

195 causal relation of abdominal adiposity with cardiometabolic risk factors in children by applying Men

196 , increasing evidence highlights the role of cardiometabolic risk factors in determining the suscepti

197 sical activity with individual and clustered cardiometabolic risk factors in healthy children aged 10

198 The burden of liver fat and associated cardiometabolic risk factors in healthy children is unkn

199 en physical activity and sedentary time with cardiometabolic risk factors in healthy children.

200 There were also significant improvements in cardiometabolic risk factors in intervention compared wi

201 and the more potent association of VFA with cardiometabolic risk factors in men and women with RA, m

202 a high prevalence of all single and combined cardiometabolic risk factors in Nepal.

203 nutrition is associated with epigenetic and cardiometabolic risk factors in offspring.

204 blocker, may reduce body weight and improve cardiometabolic risk factors in patients who are overwei

205 ation with resveratrol for the management of cardiometabolic risk factors in patients with T2D, MetS,

206 ificant and important reduction on levels of cardiometabolic risk factors in patients with type 2 dia

207 decreasing diabetes incidence and improving cardiometabolic risk factors in persons at increased ris

208 o examine the prevalence of diabetes-related cardiometabolic risk factors in this large, but little-s

209 l hyperglycemia, hyperinsulinemia, and other cardiometabolic risk factors in type 2 diabetes and, wit

210 The relation between serum 25(OH)D and cardiometabolic risk factors in US children was investig

211 lunch with that at dinner on weight loss and cardiometabolic risk factors in women during a weight-lo

212 ith LF yogurt consumption on body weight and cardiometabolic risk factors in women during a weight-lo

213 fore and during pregnancy is associated with cardiometabolic risk factors in young adult offspring.

214 We investigated cardiometabolic risk factors in young adults who were bo

215 e restriction significantly reduced multiple cardiometabolic risk factors in young, non-obese adults.

216 ubcomponent of physical activity may predict cardiometabolic risk factors in youths.We examined the i

217 al amounts of SFAs from cheese and butter on cardiometabolic risk factors.In a multicenter, crossover

218 LSG can significantly improve cardiometabolic risk factors including glycemic status i

219 Continuous AsIII exposure increased cardiometabolic risk factors including increased body we

220 studies, (2) genetic consortia for selected cardiometabolic risk factors (including body mass index

221 haled CO was associated with the presence of cardiometabolic risk factors (including smoking) and pre

222 eing developed for the treatment of multiple cardiometabolic risk factors, including abdominal obesit

223 havior modification in treatment of multiple cardiometabolic risk factors, including abdominal obesit

224 line to 2 years of all measured conventional cardiometabolic risk factors, including change scores fo

225 se migrant workers had none of the following cardiometabolic risk factors, including current cigarett

226 syndrome (MetS) refers to the clustering of cardiometabolic risk factors, including dyslipidemia, ce

227 Cardiometabolic risk factors, including fatty liver, are

228 ulting in unprecedented exposures to adverse cardiometabolic risk factors, including limited physical

229 djustment for longstanding illness and major cardiometabolic risk factors indicated that disease proc

230 e observed polygenic overlap between CAD and cardiometabolic risk factors indicates a pathogenic rela

231 Cardiometabolic risk factors influence white matter hype

232 hyperintensities (WMHs) in individuals with cardiometabolic risk factors, interfere with the traject

233 iations of Anti-Mullerian hormone (AMH) with cardiometabolic risk factors is lacking.

234 Although the prevalence of cardiometabolic risk factors is relatively low among chi

235 stigate trends for cardiovascular events and cardiometabolic risk factor levels in individuals with t

236 children with increased WHtRs have abnormal cardiometabolic risk factor levels.

237 nses to a mixed-meal shake challenge test of cardiometabolic risk factors, lipoproteins, vascular mea

238 Whether weight reduction and cardiometabolic risk factor management can reduce the bu

239 asions could lead to healthier lifestyle and cardiometabolic risk factor management.

240 Other cardiometabolic risk factors may be differently modified

241 ein signatures were strongly associated with cardiometabolic risk factors, metabolically unhealthy ob

242 Secondary outcomes were cardiometabolic risk factors, nutritional outcomes, adve

243 med at evaluating the medium-term effects on cardiometabolic risk factors of diets naturally rich in

244 that sensitize the genome to these and other cardiometabolic risk factors of the diabetic milieu are

245 tricular mass (LVM) and reduce the effect of cardiometabolic risk factors on LVM.

246 Effect modification by pre-existing cardiometabolic risk factors on the PM2.5-CVD mortality

247 as not associated with any of the individual cardiometabolic risk factors or clustered cardiometaboli

248 vements in appetite, body weight management, cardiometabolic risk factors, or all of these health out

249 ood foreclosures had mixed associations with cardiometabolic risk factors over time.

250 n, and most of the children had at least one cardiometabolic risk factor, particularly lipid disorder

251 s associated with an increased prevalence of cardiometabolic risk factors, particularly among boys an

252 The average number of cardiometabolic risk factors per participant was 2.7+/-1

253 Cardiometabolic risk factors, physical activity, diet, a

254 A growing body of evidence suggests that cardiometabolic risk factors play a significant role in

255 NT-1, tirzepatide-associated improvements in cardiometabolic risk factors positively related to the d

256 MedDiet, was associated with improvements in cardiometabolic risk factors, potentially through modula

257 r with a rapid increase in the prevalence of cardiometabolic risk factors, predominantly obesity and

258 ted with characteristics of both a favorable cardiometabolic risk-factor profile (higher HDL choleste

259 choline were associated with an unfavorable cardiometabolic risk-factor profile [lower high-density

260 sma betaine were associated with a favorable cardiometabolic risk-factor profile [lower low-density l

261 outcomes including anthropometric measures, cardiometabolic risk factors, pulmonary function, vitami

262 f the association that was mediated by the 5 cardiometabolic risk factors ranged from -17% (95% CI, -

263 d hypertensive, with increased prevalence of cardiometabolic risk factors regardless of BMI.

264 )D was significantly associated with several cardiometabolic risk factors regardless of obesity.

265 n and adolescents was associated with better cardiometabolic risk factors regardless of the amount of

266 Exploratory cardiometabolic risk factor responses to a prescribed 25

267 n percentage weight reduction and changes in cardiometabolic risk factors seemed mostly linear for wa

268 had a high prevalence of cardiovascular and cardiometabolic risk factors, similar to patients with t

269 n plasma triglycerides and potentially other cardiometabolic risk factors starting in childhood.

270 Of the cardiometabolic risk factors studied, only BMI was assoc

271 esterol concentrations, but effects on other cardiometabolic risk factors such as endothelial functio

272 HS exposure is associated with clustering of cardiometabolic risk factors such as obesity, dyslipidem

273 Cardiometabolic risk factors such as obesity, excess per

274 nical outcomes and clinical trials assessing cardiometabolic risk factors supports an aetiological ro

275 cations produce greater improvements in many cardiometabolic risk factors than placebo, but no obesit

276 verse relation between physical activity and cardiometabolic risk factors that is independent of sede

277 for metabolic syndrome (MetS), a cluster of cardiometabolic risk factors that promote development of

278 ntestinal physiology) significantly improves cardiometabolic risk factors, the effect on cardiovascul

279 n for MASLD in Hispanic/Latino patients with cardiometabolic risk factors to enable early detection a

280 y reported associations between 25(OH)D with cardiometabolic risk factors using data from NHANES were

281 For several cardiometabolic risk factors, values considered within n

282 body weight and improvement with respect to cardiometabolic risk factors (waist circumference and le

283 investigated the association between GGT and cardiometabolic risk factors; waist circumference, systo

284 mother-offspring pairs, at least 1 maternal cardiometabolic risk factor was present in 5537 (44.4%),

285 intake, energy intake, nutrient intake, and cardiometabolic risk factors was analyzed in 11,296 men

286 Cardiometabolic risk factors were assessed in 240 twin p

287 2 or more blood pressure measures, maternal cardiometabolic risk factors were associated with an inc

288 tions of parental separation with children's cardiometabolic risk factors were largely null.

289 d with the general population in China, most cardiometabolic risk factors were less prevalent in migr

290 Changes in cardiometabolic risk factors were not different between

291 Among secondary outcomes, changes in cardiometabolic risk factors were not statistically sign

292 ith a serious mental illness and one or more cardiometabolic risk factors were randomly assigned to e

293 Maternal cardiometabolic risk factors were retrieved and harmoniz

294 The polygenic risk scores (PRS) for cardiometabolic risk factors were strongly associated wi

295 Associated trajectories of cardiometabolic risk factors were studied using adjusted

296 10-y interval that included measurements of cardiometabolic risk factors, were included in the study

297 se has different effects on a broad array of cardiometabolic risk factors when compared with consumpt

298 ion between GGT was significant for all five cardiometabolic risk factors, while adjusting for age.

299 Despite weight regain, BWMPs reduce cardiometabolic risk factors with effects lasting at lea

300 For patients with T2D who had selected cardiometabolic risk factors within target ranges, compa